ClinConnect ClinConnect Logo
Search / Trial NCT04557293

Effort-based Decision-making and CPAPadherence

Launched by ISTITUTI CLINICI SCIENTIFICI MAUGERI SPA · Sep 15, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Apnoea Effort Based Decision Making Rehabilitation Adherence

ClinConnect Summary

This clinical trial is exploring why some people with obstructive sleep apnea (OSA) struggle to stick with their Continuous Positive Airway Pressure (CPAP) treatment. OSA is a common sleep disorder that can lead to serious health issues like high blood pressure, diabetes, and increased risk of heart problems. The researchers want to understand how the effort involved in using CPAP might affect patients' decisions to continue or stop using it, both before they start treatment and after they've been using it for a while.

To be eligible for this trial, participants need to be at least 18 years old and have a specific measure of sleep apnea severity. However, those with a high body mass index (BMI), certain cognitive impairments, or other sleep and psychiatric disorders won't be able to take part. If you join the study, you can expect to share your experiences and thoughts about using CPAP, which could help doctors improve support for future patients. The trial is currently looking for volunteers, and anyone aged 18 and older can apply.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18
  • AHI±15
  • Exclusion Criteria:
  • BMI ≥ 35 Kg/m2
  • MMSE \<24
  • Complex sleep apnoea
  • Sleep disorder
  • Psychiatric disorder

About Istituti Clinici Scientifici Maugeri Spa

Istituti Clinici Scientifici Maugeri S.p.A. is a prestigious Italian healthcare organization dedicated to advancing medical research and clinical practice. With a strong focus on patient-centered care, the institution integrates innovative clinical trials into its comprehensive services, fostering collaboration between researchers and healthcare professionals. Known for its commitment to high-quality standards and ethical practices, Istituti Clinici Scientifici Maugeri S.p.A. plays a pivotal role in the development of new therapies and treatment modalities, contributing significantly to the global medical community and enhancing patient outcomes.

Locations

Pavia, , Italy

Patients applied

0 patients applied

Trial Officials

Nicola Canessa, PhD

Principal Investigator

IRCCS Istituti Clinici Scientifici Maugeri - Scuola superiore IUSS Pavia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials